Business Week — Pfizer’s Fallout
Political fallout from the Pfizer decision not to fund medical communication companies (MECC's) in July, includes a Business Week…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Massachusetts S2660: Confusing “compromise” on Massachusetts…
There was a confusing compromise leading to the passage of a modified gift ban by the Massachusetts…
Senator Kohl: IDEA Act – Government Sales Reps Coming Soon
Coming Soon to your local physicians office may be sales reps from the Federal Government.
Senator Kohl, of…
Grassley and Dingell: Wanted a New Sherriff for the FDA
We need a new Sherriff is the call of several key members of congress including (Senator Grassley, Republican from Iowa and…
Drug Development – The need for a little serendipity
Why does drug development require so much serendipity? Why do drugs take so long to develop? Why is there are there…
Grassley: GAO Looks at Off Label Marketing
This weekend the Associated Press (AP) wrote a story FDA Faulted over unapproved uses of medications about a draft…
NLARX: Singing the Blues in New Orleans
Several months ago National Legislative Association to Reduce Prescription Prices (NLARX) announced that their satellite…
Patient Assistance Programs — Free Enterprise at Work
In a world of bad news for pharmaceutical companies one item crossed my desk that deserves some note. Patient assistance…
Massachusetts S2660 — Time to Encourage the State Senate
Today the Boston Globe reported that House OKs healthcare bill without ban on gifts
The Massachusetts State House passed the…
Massachusetts S2660 — Gift Ban Goes Bye Bye
In a move that shows legislators in Massachusetts understand the need for manufactures and physicians to continue to work…